Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Immunotherapy|April 6, 2013
Targeting EBV's Achilles' heel with antigen-specific T cellsMamta Kalra, Stephen Gottschalk
Clinical Immunology (Orlando, Fla.)|January 9, 2007
Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicitySuraj B Sable, Mamta Kalra, Indu Verma, et al.
Indian Journal of Experimental Biology|May 12, 2010
Evaluation of Mycobacterium tuberculosis specific RD antigens for delayed type hypersensitivity responses in guinea pigMamta Kalra, Gopal Krishen Khuller, Javaid Ahmad Sheikh, et al.
World Journal of Gastroenterology|October 22, 2008
Role of sex steroid receptors in pathobiology of hepatocellular carcinomaMamta Kalra, Jary Mayes, Senait Assefa, et al.
Diagnostic Microbiology and Infectious Disease|January 18, 2012
Development of an ultrasensitive polymerase chain reaction-amplified immunoassay based on mycobacterial RD antigens: implications for the serodiagnosis of tuberculosisPromod K Mehta, Mamta Kalra, Gopal Krishan Khuller, et al.
World Journal of Gastroenterology|November 1, 2017
Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesisJanaki K Iyer, Mamta Kalra, Anil Kaul, et al.
Diagnostic Microbiology and Infectious Disease|October 17, 2009
Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosisMamta Kalra, Gopal Krishan Khuller, Ajay Grover, et al.
Cytotherapy|November 7, 2018
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapyMamta Kalra, Ulrike Gerdemann, Jessica D Luu, et al.
Clinical Immunology (Orlando, Fla.)|September 4, 2007
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous miceMamta Kalra, Ajay Grover, Neena Mehta, et al.
Pageof 2